共 50 条
- [33] Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’ British Journal of Cancer, 2017, 116 : e14 - e14
- [34] Abscopal Effect in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors (Anti-CTLA-4 and Anti-PD1): A Retrospective Analysis of a Single Institution INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S159 - S159
- [38] The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 89 - 89